Chronic Kidney Failure
📧 Sign up to get email alerts when something new happens for Chronic Kidney Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-19Clinical Trial Update: Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase [NA]
RAND-sponsored pilot clinical trial evaluating EHR nudges to reduce high-risk polypharmacy in older adults has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Exercise Training and Kidney Transplantation [NA]
A completed clinical trial evaluated exercise training in kidney transplant recipients and examined effects on solid organ transplant reject…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Pentoxifylline for Vascular Calcification in Kidney Disease [Phase 1, Phase 2]
A clinical trial update indicates a Phase 1/Phase 2 study of pentoxifylline for vascular calcification in chronic kidney disease is not yet …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Reduction of Heparin Dose in Dialysis With Evodial System [NA]
This clinical trial update reports on the assessment of reducing the heparin dose during dialysis using the Evodial System; the trial has co…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line [NA]
A completed clinical trial comparing the biocompatibility of a cartridge blood set versus a standard blood line for use in patients with Chr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction [Phase 3]
A Phase 3 clinical trial update exploring belatacept as a transient replacement for calcineurin inhibitors from 3 to 12 months after transpl…
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: An Innovative Virtually Supervised Exercise for Dialysis Patients [Phase 2]
Phase 2 trial update on a virtually supervised exercise program for dialysis patients.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: New Non-invasive Methods for Real-time Monitoring of Organ Function.
A completed clinical trial update on new non-invasive methods for real-time monitoring of organ function, with a focus on kidney function in…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery [Phase 2]
Phase 2 clinical trial entry reporting a completed study of N-acetylcysteine and fenoldopam as renal protection agents during cardiac surger…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study on converting kidney transplant patients from tacrolimus to efalizumab maintenance ther…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 trial evaluating N-acetylcysteine's effect on hydrogen sulfide in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients [Phase 2]
A Phase 2 clinical trial evaluating magnesium iron hydroxycarbonate to reduce high blood phosphate in hemodialysis patients has completed; n…
-
EMA withdrawal · 2009-04-23EMA Withdrawn: Dynepo (epoetin delta) — Shire Pharmaceutical Contracts Limited
Dynepo (epoetin delta) has been withdrawn from the market by Shire Pharmaceutical Contracts Limited.